Cargando…

Cannabinoids and Multiple Sclerosis: A Critical Analysis of Therapeutic Potentials and Safety Concerns

Multiple sclerosis (MS) is a complicated condition in which the immune system attacks myelinated axons in the central nervous system (CNS), destroying both myelin and axons to varying degrees. Several environmental, genetic, and epigenetic factors influence the risk of developing the disease and how...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nouh, Roua A., Kamal, Ahmed, Abdelnaser, Anwar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146800/ https://www.ncbi.nlm.nih.gov/pubmed/37111637 http://dx.doi.org/10.3390/pharmaceutics15041151

Ejemplares similares

Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis?
por: Giacoppo, Sabrina, et al.
Publicado: (2016)

Cannabinoids in the management of spasticity associated with multiple sclerosis
por: Malfitano, Anna Maria, et al.
Publicado: (2008)

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity
por: Patti, F, et al.
Publicado: (2016)

Therapeutic Potential of Cannabinoids in Glaucoma
por: Lindner, Theresa, et al.
Publicado: (2023)

Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis
por: Gado, Francesca, et al.
Publicado: (2018)

The Pathophysiology and the Therapeutic Potential of Cannabinoids in Prostate Cancer
por: Singh, Kanika, et al.
Publicado: (2021)

New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids
por: Smith, Paul F
Publicado: (2010)

Critical appraisal of the potential use of cannabinoids in cancer management
por: Cridge, Belinda J, et al.
Publicado: (2013)

Safety and Toxicology of Cannabinoids
por: Sachs, Jane, et al.
Publicado: (2015)

Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease
por: Dibba, Pratima, et al.
Publicado: (2018)

PPAR-γ: Therapeutic Potential for Multiple Sclerosis
por: Drew, Paul D., et al.
Publicado: (2008)

Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats
por: Feige, Julia, et al.
Publicado: (2020)

Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets
por: Govindarajan, Vaidya, et al.
Publicado: (2020)

Non-Cannabinoid Metabolites of Cannabis sativa L. with Therapeutic Potential
por: Lowe, Henry, et al.
Publicado: (2021)

A Critical Review of the Role of the Cannabinoid Compounds Δ(9)-Tetrahydrocannabinol (Δ(9)-THC) and Cannabidiol (CBD) and their Combination in Multiple Sclerosis Treatment
por: Jones, Éamon, et al.
Publicado: (2020)

The Transdermal Delivery of Therapeutic Cannabinoids
por: Mahmoudinoodezh, Haleh, et al.
Publicado: (2022)

Cannabinoid ligands, receptors and enzymes: Pharmacological tools and therapeutic potential
por: Hourani, Wafa, et al.
Publicado: (2018)

The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue
por: Kirby, Trevor O., et al.
Publicado: (2018)

Cannabinoids and agmatine as potential therapeutic alternatives for cisplatin-induced peripheral neuropathy
por: Donertas, Basak, et al.
Publicado: (2018)

Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
por: Tóth, Kinga Fanni, et al.
Publicado: (2019)

Therapeutic Potential of Minor Cannabinoids in Dermatological Diseases—A Synthetic Review
por: Kwiecień, Emilia, et al.
Publicado: (2023)

Safety Considerations in Cannabinoid-Based Medicine
por: Gottschling, Sven, et al.
Publicado: (2020)

Cannabinoids: Therapeutic Use in Clinical Practice
por: Pagano, Cristina, et al.
Publicado: (2022)

An Overview of Therapeutic Options in Relapsing-remitting Multiple Sclerosis
por: Saleem, Sidra, et al.
Publicado: (2019)

Special Issue: Therapeutic Potential for Cannabis and Cannabinoids
por: Raup-Konsavage, Wesley M.
Publicado: (2023)

The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis
por: Storoni, Mithu, et al.
Publicado: (2015)

Cannabis, Cannabinoids, and the Endocannabinoid System—Is there Therapeutic Potential for Inflammatory Bowel Disease?
por: Ambrose, Tim, et al.
Publicado: (2019)

Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications
por: Hashiesh, Hebaallah Mamdouh, et al.
Publicado: (2020)

Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
por: Vuic, Barbara, et al.
Publicado: (2022)

Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity
por: Vasincu, Alexandru, et al.
Publicado: (2023)

Novel Insights and Therapeutics in Multiple Sclerosis
por: Wagner, Catriona A., et al.
Publicado: (2015)

Multiple Sclerosis and Serotonin: Potential Therapeutic Applications
por: San Hernandez, Aleyda M, et al.
Publicado: (2020)

Therapeutic Potential of Cannabinoids on Tumor Microenvironment: A Molecular Switch in Neoplasia Transformation
por: Bakshi, Hamid A., et al.
Publicado: (2022)

Review of daclizumab and its therapeutic potential in the treatment of relapsing–remitting multiple sclerosis
por: Reardon, Jennifer, et al.
Publicado: (2013)

Multiple Sclerosis: Focus on Extracellular and Artificial Vesicles, Nanoparticles as Potential Therapeutic Approaches
por: Nuzzo, Domenico, et al.
Publicado: (2021)

New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
por: Kibret, Berhanu Geresu, et al.
Publicado: (2022)

Unleashing nature's potential and limitations: Exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis (Review)
por: Fathallah, Sara, et al.
Publicado: (2023)

Endo-cannabinoids system and the toxicity of cannabinoids with a biotechnological approach
por: Niaz, Kamal, et al.
Publicado: (2017)

Editorial: Therapeutic potential of the cannabinoid CB2 receptor
por: Smoum, Reem, et al.
Publicado: (2022)

Multiple Sclerosis: A Global Concern with Multiple Challenges in an Era of Advanced Therapeutic Complex Molecules and Biological Medicines
por: Rivera, Victor M.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2jija4297mq0t0m0b8n0np496k